Article
The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis.
Journal of cellular and molecular medicine - 1 Jan 2000
Sfrent-Cornateanu Roxana, Mihai Carina, Balan Simona, Ionescu R, Moldoveanu E
Abstract excerpt
UNLABELLED: Systemic sclerosis (SSc) is a rare, autoimmune disease characterized by cutaneous and visceral fibrosis. Interleukin- 6 (IL-6) is involved in the pathogenesis of many immune-mediated diseases. IL-6 plays an important role in the initiation and promotion of fibrosis. The polymorphism in the position -174 (G/C) of the promoter region of the IL-6 gene (IL-6pr) may alter the expression of the gene....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
